Relationships between race, gender, and spot urine levels of biomarkers of tobacco exposure vary based on how creatinine is handled in analyses.

INTRODUCTION We illustrate the differential impact of common analysis approaches to handling urinary creatinine, a measure for urine dilution, on relationships between race, gender, and biomarkers of exposure (BOE) measured in spot urine. METHODS In smokers, spot urine levels of total nicotine equivalents (TNE, sum of total nicotine, total cotinine and total 3'-hydroxycotinine) and total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) overall and per cigarette were examined. Relationships between race (African Americans[AA] n=373,Whites n=758) or gender (males n=629,females n=502) and TNE or NNAL were examined using the following approaches to handling creatinine: 1) unadjusted/unstandarized; 2) standardization; 3) adjustment as a covariate. Significance was considered at p<0.05. RESULTS Creatinine was higher in AA versus Whites(1.19 vs 0.96 mg/mL; p<.0001) and in males versus females(1.21 vs 0.84 mg/mL; p<.0001). Independent of how creatinine was handled, TNE was lower among AA than Whites (TNE ratios AA vs Whites:0.67-0.84; ps<0.05). Unadjusted TNE per cigarette was higher among AA versus Whites (ratio 1.12; p=0.0411); however, the relationship flipped with standardization (ratio 0.90; p=0.0360) and adjustment (ratio 0.95; p=0.3165). Regarding gender, unadjusted TNE was higher among males versus females (ratio 1.13; p =0.0063), but the relationship flipped with standardization (ratio 0.79; p<.0001) or adjustment (ratio 0.89; p-value=0.0018). Unadjusted TNE per cigarette did not differ across gender (ratio 0.98; p=0.6591), but lower levels were found in males versus females with standardization (ratio 0.68; p<.0001) and adjustment (ratio 0.74; p<.0001). NNAL displayed similar patterns. CONCLUSIONS Relationships between race, gender, and spot urine levels of BOE can vary greatly based on how creatinine is handled in analyses. IMPLICATIONS Lack of appropriate methods can lead to discrepancies across reports on variability of urinary biomarkers by race and gender. We recommend that for any analyses of BOE measure in spot urine samples across race, gender, or other population subgroups that differ in urinary creatinine levels, sensitivity analyses comparing the different methods for handling urinary creatinine should be conducted. If methods result in discrepant findings, this should be clearly noted and discussed.

[1]  D. Hatsukami,et al.  Biomarkers of Exposure and Potential Harm among Natural American Spirit Smokers. , 2019, Tobacco regulatory science.

[2]  A. Hyland,et al.  Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes , 2018, JAMA network open.

[3]  Jason D. Robinson,et al.  Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial , 2018, JAMA.

[4]  T. Wagener,et al.  Biomarkers of Exposure in ENDS Users, Smokers, and Dual Users of American Indian Descent. , 2018 .

[5]  S. Gortmaker,et al.  Racial/Ethnic and Socioeconomic Disparities in Hydration Status Among US Adults and the Role of Tap Water and Other Beverage Intake , 2017, American journal of public health.

[6]  D. Hatsukami,et al.  Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[7]  L. Le Marchand,et al.  Variation in Levels of the Lung Carcinogen NNAL and Its Glucuronides in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[8]  S. Hecht,et al.  High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. , 2013, Chemical research in toxicology.

[9]  N. Benowitz,et al.  Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure. , 2013, Addiction.

[10]  R. Jain,et al.  Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the united states: NHANES 2007–2008 , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[11]  P. Villalta,et al.  Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.